“I am interested in current survival outcomes for patients with recurrent glioblastoma, both all patients and those that undergo surgical resection. This is extremely impressive and interesting, especially since I wasn’t sure there would be sufficient data to look at with and without resection! Very interesting to see about CAR-Ts and checkpoint inhibitors as well!”
